DIAGNOSIS AND MANAGEMENT OF PULMONARY EMBOLISM

Monday, March 10, 2025

1:30 PM – 2:53 PM ET

Moderator(s)

Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure(s): Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)
Rachel Rosovsky, MD, MPH

Associate Professor, Harvard Medical school
Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure(s): Boston Scientific Corporation: Consultant (Ongoing); Inquis Medical: Consultant (Ongoing); Janssen Pharmaceuticals: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Global PI for International device trial; research funds go to my institution (Ongoing), Grant/Research Support (Ongoing)
Andrew SP Sharp, MD

Professor of Cardiology
University College Dublin
Dublin, Ireland

Disclosure(s): AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Kenneth Rosenfield, MD, MHCDS: Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)

Rachel Rosovsky, MD, MPH: Boston Scientific Corporation: Consultant (Ongoing); Inquis Medical: Consultant (Ongoing); Janssen Pharmaceuticals: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Global PI for International device trial; research funds go to my institution (Ongoing), Grant/Research Support (Ongoing)

Andrew SP Sharp, MD: AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)